137 related articles for article (PubMed ID: 35861939)
1. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma.
Li SH; Qian L; Chen YH; Lu HI; Tsai HT; Lyu H; Yang R; Chen CH
J Cell Physiol; 2022 Sep; 237(9):3671-3686. PubMed ID: 35861939
[TBL] [Abstract][Full Text] [Related]
2. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
3. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA‑449a‑5p promotes esophageal squamous cell carcinoma cell proliferation via cyclin D1 regulation.
Jiang T; Liu J; Mu J
Mol Med Rep; 2018 Jul; 18(1):848-854. PubMed ID: 29845226
[TBL] [Abstract][Full Text] [Related]
5. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
[TBL] [Abstract][Full Text] [Related]
7. Pin1 positively affects tumorigenesis of esophageal squamous cell carcinoma and correlates with poor survival of patients.
Lin FC; Lee YC; Goan YG; Tsai CH; Yao YC; Cheng HC; Lai WW; Wang YC; Sheu BS; Lu PJ
J Biomed Sci; 2014 Aug; 21(1):75. PubMed ID: 25160749
[TBL] [Abstract][Full Text] [Related]
8. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
10. Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.
Jiang L; Zhao Z; Zheng L; Xue L; Zhan Q; Song Y
Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):208-217. PubMed ID: 28602785
[TBL] [Abstract][Full Text] [Related]
11. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
12. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
[TBL] [Abstract][Full Text] [Related]
14. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR‑145‑3p on gene regulation.
Shimonosono M; Idichi T; Seki N; Yamada Y; Arai T; Arigami T; Sasaki K; Omoto I; Uchikado Y; Kita Y; Kurahara H; Maemura K; Natsugoe S
Int J Oncol; 2019 Feb; 54(2):673-688. PubMed ID: 30535463
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
18. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
19. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
[TBL] [Abstract][Full Text] [Related]
20. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]